Oftalamine: bayanin, umarni, farashi

Tabletsauki allunan 1 zuwa 2 Ammar Sau 2 a rana kafin abinci.
Yawan izinin shiga kwanaki 20-30.
Yana da kyau a sake maimaita karatun bayan watanni 4-6.

Sakamako masu illa:
Lokacin amfani da miyagun ƙwayoyi Nazazzaman ba a gano sakamako masu illa ba.

Ophthalamin ®

Kada kayi amfani bayan ranar karewa wanda aka nuna akan kunshin.

Ka bar bayananka

Neman Bayanan Bincike na Yanzu, ‰

  • RU.77.99.88.003.E.002869.02.15

Shafin gidan yanar gizon kamfanin RLS ®. Babban encyclopedia na kwayoyi da kayayyaki na kantin magani na Rasha yanar-gizo. Kundin adireshi na Rlsnet.ru yana ba masu amfani damar samun umarni, farashi da kwatancin magunguna, kayan abinci, na’urorin likitanci, na’urorin likita da sauran kayayyaki. Jagorar magunguna ta hada da bayani kan abun da ya kunsa da kuma nau'in sakin, aikin pharmacological, alamu don amfani, contraindications, sakamako masu illa, hulɗa da miyagun ƙwayoyi, hanyar amfani da kwayoyi, kamfanonin harhada magunguna. Takaddun magungunan ya ƙunshi farashin magunguna da samfuran magunguna a Moscow da sauran biranen Rasha.

An hana shi yada, kwafi, watsa bayanai ba tare da izinin RLS-Patent LLC ba.
Lokacin ɗauko abubuwan bayanan da aka buga a shafukan yanar gizon www.rlsnet.ru, ana buƙatar hanyar haɗi zuwa asalin bayanin.

Abubuwa da yawa masu ban sha'awa

An kiyaye duk haƙƙoƙi

Ba a ba da izinin amfani da kayan kayan kasuwanci ba.

Bayanin an yi nufin ne don ƙwararrun likitoci.

Tambayoyi, amsoshi, sake dubawa game da magani na Oftalamin


Bayanin da aka bayar an yi shi ne don ƙwararrun likitoci da magunguna. Cikakken bayani game da magani yana kunshe ne a cikin umarnin da aka haɗe zuwa marufin da mai masana'anta. Babu wani bayani da aka sanya akan wannan ko wani shafin yanar gizon mu wanda zai iya canza matsayin roko na musamman ga kwararrun.

Farashin Oftalamine da kuma kasancewa a cikin magunguna na garin

Hankali! A saman tebur ne mai duba, mai yiwuwa bayanai sun canza. Bayanai kan farashi da samuwar canji a ainihin lokacin don ganin su - zaku iya amfani da binciken (koyaushe har zuwa bayanin yau da kullun a cikin binciken), sannan kuma idan kuna buƙatar barin umarni don magani, zaɓi wuraren birni don bincika ko bincika kawai ta hanyar buɗe a yanzu. magunguna.

Jerin da ke sama an sabunta aƙalla a kowane awanni 6 (an sabunta shi a ranar 07/18/2019 a 18:42 - lokacin Moscow). Sanya farashi da wadatar magunguna ta hanyar bincike (mashaya binciken yana saman), kazalika da lambobin waya na kantin magani kafin ziyartar kantin magani. Ba za a iya amfani da bayanin da ke shafin ba a matsayin shawarwari don magani na kai. Kafin yin amfani da magunguna, tabbatar da cewa ka nemi likitanka.

Rashin aikin tiyata na zamani

Ophthalamin - ƙarin abincin abinci mai aiki (cytamine), mai nazarin halittu na gabobin hangen nesa, yana ba da gudummawa ga daidaituwa da haɓaka ayyukan gani a cikin rikice-rikice iri iri da raunin idanu. Hakanan za'a iya bada shawarar don tashin hankali na gani da gajiyawar ido.

KYAUTATA DA KYAUTA NA ISA

Oftalamine - Allunan kwayoyi 155 a cikin harsashi, kowane ɗayansu ya ƙunshi:

  • Babban abu: ophthalamine foda, an samo shi daga kyallen ƙwallon ido na aladu da shanu (hadadden ƙwayoyin polypeptides, acid na nucleic) - 10 MG.
  • Elementsarin abubuwa: lactose, sitaci dankalin turawa, sitaci sittin sitiriɗ, methyl cellulose, ruɓaɓɓen shafi.

Kamawa. Kwalaben farin filastik na allunan 20 a cikin fakitin kwali.

MAGANAR PHARMACOLOGICAL

Oftalamine foda ne wanda aka samu daga kyallen idanun dabbobi. Hadaddun abubuwa ne na nucleoproteins da sunadarai wadanda suke da tasirin zabi akan tsarin kwayar halittar idanu. Amfani da ophthalamine yana taimakawa hanzarta maido da ayyukan gani idan lalacewar gabobin hangen nesa daga asalin halitta.

Oftalamine samfurin an bada shawarar don amfani dashi don hanzarta maido da ayyukan abubuwan kyallen idanu a cikin raunin da ya faru, gami da cututtukan cututtukan cututtukan fata na retina da nakasassun jijiyoyin jiki. Hakanan za'a iya ba da shawarar ga tsofaffi, azaman hanyar tallafawa ayyukan sashen hangen nesa.

Leave Your Comment